MGMT and glioblastoma: The importance of the establishment of the clinically relevant level of methylation of a biomarker was recently highlighted by Hegi et al. [14] in a large-scale clinical study of the diagnostic utility of the MGMT gene methylation testing in patients with newly diagnosed glioblastoma (GBM).